Scientists have identified two new bacterial molecules that were present in both the gut and the brain of mice.
New molecules which form a direct link between the gut microbiome and the brain have been discovered by scientists at the University of Glasgow. The new finding leads to inhibition of brain cell function in pre-clinical investigations in mice. // In the study, conducted in collaboration with AstraZeneca and published today in Science Advances, scientists were able to identify two new bacterial molecules that were present in both the gut and the brain of mice.
‘Given alterations in our gut microbiome has been linked to a number of neurological conditions, understanding the means of microbial communication between the gut and the brain is more important than ever.’
The researchers used a technique called mass spectrometry imaging (MSI) to map these molecules, which were produced by bacteria in the gut microbiome, before they travelled to distinct parts of the brain. The molecules – which were found within specific regions of the mouse brain– have a similar structure to carnitine, a molecule used to help burn fatty acids for energy.
Alterations to the gut microbiome are associated with various neurological diseases, yet evidence of a direct interaction between gut microbiome compounds and the brain has remained elusive.
Dr Dόnal Wall, from the University’s Institute of Infection, Immunity and Inflammation, said: “Communication between the gut microbiome and the brain is now recognized as playing an important role in neurological health. The novel techniques we used in this study allowed us to demonstrate a molecular exchange between the gut microbiome and the brain, which could be of biological importance in many diseases.
“In this study, the microbiome compounds we found – which ‘mimic’ and localize with carnitine after travelling to the brain in the mice we studied, also affected its function, making it an extremely important finding for ongoing research in this area.”
Advertisement
The two novel molecules produced by the gut microbiome described in the study are the first that can cross into the brain of mouse models and localize with, and antagonize, the function of carnitine.
Advertisement
Dr Richard Goodwin, Head of Imaging & AI, Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, commented: “Advances in imaging technologies, such as mass spectrometry imaging (MSI), are enabling scientists to see in unprecedented detail the events that are happening within their samples. This collaboration is a great example of how MSI can be utilized in an innovative way to provide valuable scientific insight to deepen understanding of a previously poorly understood molecular relationship.”
The paper, ‘Microbiome-derived carnitine mimics as novel mediators of gut-brain axis communication’ is published in Science Advances. The work was funded by the Biotechnology and Biological Sciences Research Council (BBSRC) and AstraZeneca.
Source-Medindia